Industry
ACMD urged to back rescheduling of cannabis to open up research
The Cannabis Industry Council (CIC), has called on the ACMD to recommend to the Home Office that cannabis be rescheduled for research purposes.
Search
24 results for “medical-cannabis-report”
Case Studies
How cannabis can improve quality of life for dementia patients – a case study
Dr Niraj Singh shares the case of a dementia patient who has seen improvements in mood, expression and quality of life.
Science
Journal Club: Can medical cannabis help anxiety and depression?
The Journal Club explores the latest research for the use of cannabis in anxiety and depression.
Pain
Project Twenty21 publishes first findings on chronic pain
Data from over 900 medical cannabis patients, living with chronic pain, has been published this week.
Mental health
New data supports use of medical cannabis for anxiety and depression
The study is thought to be the largest to date examining medical cannabis for anxiety and depression
Epilepsy
Experts publish advice on prescribing medical cannabis for epilepsy
UK experts have welcomed the guidance as a “step in the right direction”
Fibromyalgia
UK trial of cannabinoids as treatment for fibromyalgia expected this year
The trial hopes to be recruiting patients in the coming months, subject to NHS approval.
Pain
Medical cannabis and neuropathic pain – a case study
David*, a patient from MyAccess Clinics, has been taking medical cannabis for neuropathic pain for over 18 months.
Industry
Decalogue: Increasing access and clinical understanding of medicinal cannabis
Alex Fraser, patient access lead for Grow Pharma, reviews one the the latest cannabis industry events.
Industry
71% of CBD consumers see improvement in wellbeing
3,000 people took part in the ‘first of its kind’ study
News
68% of IBD patients saw improvements with cannabis – study
Although the study highlighted that a large percentage did not discuss their usage with their doctor or specialist.
Advocacy
Medical cannabis campaigners share anger at reading of new bill in parliament
“This is simply unforgivable. What a smack in the face this is for our families and at Christmas too. So once again, we get warm words, but no solution.”
Advocacy
Families to gather at Parliament to condemn three-year failure of medical cannabis policy
Patients have been faced with a series of obstacles in their quest for access to NHS prescriptions
Pain
New UK trials to study medical cannabis and chronic pain
A trial at the University of Manchester will study cannabinoids in patients with fibromyalgia and chronic pain
Industry
Elite Growth aims at the Premier League for patients
Elite Growth is on a mission to transform the global medical cannabis market. Its team of experts and industry veterans reveal how.
Advocacy
“A total failure of government policy” – Medical cannabis to be discussed in Parliament
Campaigners react to the news that MP Christine Jardine will raise the issue of NHS access for medical cannabis in a parliamentary debate tonight.
Health
One in five autism caregivers give their child CBD products
A new report by reveals that the majority of parents started using oils during the pandemic for older children.
Industry
Report highlights huge potential of cannabis-based drugs
The report suggests that new cannabinoid therapeutics will be approved across the globe for various medical conditions
Advocacy
“Families have had enough of being unseen and unheard” – Campaigners react to landmark medical cannabis report
Campaigners have reacted to a landmark report published this week highlighting the impact of medical cannabis
Advocacy
“Her life was transformed” – New article shares benefits of medical cannabis for families
A new report clearly shows the benefits and changes experienced by patients and carers looking after children who use medical cannabis
News
Why drug reform advocates must move away from activism to make change
The pro-drug reform lobby must change to push its agenda ahead, experts have warned.
News
My experience as a medical cannabis prescriber on Project Twenty21
In the second of a two-part series, Cannabis Health speaks to Dr Rebecca Moore about her experience as a prescriber on Drug Science’s Project Twenty21. Project Twenty21 is a landmark […]
News
What is the risk of dependence in medical cannabis patients?
Researchers in the UK are exploring the risks of developing dependence among medical cannabis patients. Recreational users have an estimated 8.9 percent chance of developing cannabis dependence, but experts argue […]
News
LYPHE Group imports flower-based cannabis products to UK
Supplies of flower-based medical cannabis products available in the UK are continuing to grow, as the LYPHE Group imports Northern Green Canada into the market. LYPHE Group, one of the […]